The Gabelli Healthcare & Wellness Trust (GRX) Stock Score, Valuation & Financial Research
The Gabelli Healthcare & Wellness Trust is in the Financial Services sector and Asset Management industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 21/100.
Quick answer for GRX
The Gabelli Healthcare & Wellness Trust currently has a Wall Street Score of 21/100. The stored market price is $9.66. Its financial score is 5/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What The Gabelli Healthcare & Wellness Trust does
The Gabelli Healthcare & Wellness Trust operates as a closed-ended equity fund, originally established by GAMCO Investors, Inc. Gabelli Funds, LLC serves as its investment manager. This fund's mandate is to invest globally in public equities, with a predominant focus on companies operating within the healthcare and wellness sectors. It considers businesses irrespective of their market capitalization, investing across the full spectrum. To gauge its performance, the Trust benchmarks its portfolio against the S&P 500 Index, the S&P 500 Consumer Staples Index, and the S&P 500 Health Care Index. Formed on February 20, 2007, The Gabelli Healthcare & Wellness Trust is domiciled in the United States.
GRX financial snapshot
- Wall Street Score:
- 21/100
- Current price:
- $9.66
- Market capitalization:
- $142.7M
- Revenue:
- $30.3M
- Net income:
- $2.0M
- Free cash flow:
- $9.4M
- Cash:
- $18K
- Total debt:
- $70.7M
- EPS:
- 0.13
- P/E ratio:
- 72.0x
- Financial score:
- 5/100
- Valuation score:
- 0/100
- Revenue score:
- 46/100
What stands out
- Reported year-over-year revenue growth is +1.0%.
- Free cash flow is $9.4M, showing positive cash generation.
- The balance sheet shows $18K of cash versus $70.7M of total debt, so leverage deserves attention.
- The current research record carries a listed fund vehicle warning, which should be reviewed alongside the score.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 5/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-07.
How to research GRX
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.